Literature DB >> 103485

Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid.

K P Johnson, B J Nelson.   

Abstract

Early, atypical, or progressive cases of multiple sclerosis (MS) may be hard to diagnose. Until recently, assays of the most common abnormalities in cerebrospinal fluid were not available in clinical diagnostic laboratories, but now they can be done with relative ease and adequate standardization. With the newer techniques the CSF is abnormal in more than 90% of clinically definite cases of MS, and determination of such changes can be a major aid in diagnosis. The most common CSF abnormalities are discussed: elevation of immunoglobulin G(IgG), expressed as percentage of total protein; elevation of the IgG/albumin index; and presence of oligoclonal IgG bands. Not only does assessment of these CSF proteins provide an improved aid to diagnosis, but their study may furnish important clues to the cause and pathogenesis of MS as well.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 103485     DOI: 10.1002/ana.410020515

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Effects of experimental recombinant interferons on multiple sclerosis.

Authors:  K P Johnson; H S Panitch
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

2.  Abnormal protein patterns in multiple sclerosis.

Authors:  J Y Wu; K M Welch; C C Duncan
Journal:  Neurochem Res       Date:  1979-12       Impact factor: 3.996

3.  Immunoglobulin G in multiple sclerosis brain.

Authors:  T Hosokawa; J C Hunt; J J Marchalonis; E L Hogan
Journal:  Metab Brain Dis       Date:  1988-09       Impact factor: 3.584

4.  An unusual form of measles meningoencephalitis. A report of two cases.

Authors:  I Derakhshan; A Shafii; J Lotfi; K Abbassioun; J J Scillian
Journal:  J Neurol       Date:  1979-09       Impact factor: 4.849

5.  CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis.

Authors:  Matteo Lucchini; Valeria De Arcangelis; Geny Piro; Viviana Nociti; Assunta Bianco; Chiara De Fino; Gabriele Di Sante; Francesco Ria; Paolo Calabresi; Massimiliano Mirabella
Journal:  Mol Neurobiol       Date:  2022-10-10       Impact factor: 5.682

6.  B cells as a target of immune modulation.

Authors:  Kathleen Hawker
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

7.  Oligoclonal IgG in rabbits with experimental allergic encephalomyelitis: non-reactivity of the bands with sensitizing neural antigens.

Authors:  C C Whitacre; D H Mattson; E D Day; D J Peterson; P Y Paterson; R P Roos; B G Arnason
Journal:  Neurochem Res       Date:  1982-10       Impact factor: 3.996

8.  Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activity.

Authors:  C N Baxevanis; G J Reclos; C Sfagos; E Doufexis; C Papageorgiou; M Papamichail
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

9.  Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro.

Authors:  R L Hirsch; H S Panitch; K P Johnson
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

Review 10.  Multiple sclerosis.

Authors:  S G Lynch; J W Rose
Journal:  Dis Mon       Date:  1996-01       Impact factor: 3.800

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.